Comment: Mapping the terrain of investment in global infectious diseases

The Lancet Infectious Disease
Jan 2013  Volume 13  Number 1  p1 – 96

Mapping the terrain of investment in global infectious diseases
Yiannis Kyratsis, Raheelah Ahma

The limited resources available for research into global infectious diseases make the setting of priorities inevitable. The priorities of funding agencies largely dictate the type of research done, as well as the health issues and diseases studied.1 Global health research governance needs to be transparent while the funders make difficult choices with the aim of channelling funds where most needed. This openness is crucial for maintaining public confidence and continued support. Defining public need is not straightforward.